{
  "docId": "019de075-c130-77ea-b60f-b21955e0fc8e",
  "docSlug": "71c1598fd07d494c4a73d86584bdcfa9",
  "documentTitle": "Nuvalent | Investor Presentation Deck | 39 slides",
  "authorId": "nuvalent",
  "authorName": "Nuvalent",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-08-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 21,
  "pageCount": 39,
  "prevPage": 20,
  "nextPage": 22,
  "slideType": "traction",
  "function": "show_traction",
  "density": "dense",
  "nDataPoints": 17,
  "notes": "The chart uses a waterfall plot to visualize clinical efficacy, a standard in oncology drug development.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de075-c130-77ea-b60f-b21955e0fc8e/21",
  "deckHref": "/decks/019de075-c130-77ea-b60f-b21955e0fc8e",
  "deckJsonHref": "/decks/019de075-c130-77ea-b60f-b21955e0fc8e.json",
  "deckAnchorHref": "/decks/019de075-c130-77ea-b60f-b21955e0fc8e#slide-21",
  "components": [
    {
      "bbox": {
        "h": 0.55,
        "w": 0.75,
        "x": 0.17,
        "y": 0.18
      },
      "kind": "chart",
      "text": "Waterfall plot of best percentage change in target lesions",
      "attrs": null,
      "subkind": "waterfall",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ef956268-143b-4324-a3df-6988dfe7b4ea",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.85,
        "x": 0.07,
        "y": 0.85
      },
      "kind": "disclaimer",
      "text": "Data as of 13 Sep 22, for response-evaluable patients with NSCLC treated by 01 Sep 2022. Source: Drilon A. et al., EORTC-NCI-AACR 2022.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "20c84026-b26c-428e-8290-514f60c4677b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.08,
        "x": 0.07,
        "y": 0.25
      },
      "kind": "legend",
      "text": "Dose level color key",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "61f3cfa1-7607-4797-85fa-6da24b968db9",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.22,
        "w": 0.85,
        "x": 0.07,
        "y": 0.62
      },
      "kind": "table",
      "text": "Dose level and prior therapy history table",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "28f0f3b6-c007-4603-9b0c-7b157e03a006",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.85,
        "x": 0.07,
        "y": 0.06
      },
      "kind": "title",
      "text": "Preliminary Efficacy | Radiographic Tumor Regression Observed Across All NVL-520 Dose Levels",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b8358ef3-3e00-45ea-9ed1-7d54ba68d975",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Waterfall chart",
      "slug": "waterfall-chart",
      "agent": null,
      "layer": "slide",
      "matchId": "763b8443-acb9-467b-9ee8-c0d325ed661a",
      "evidence": "chart/waterfall: Waterfall plot of best percentage change in target lesions",
      "confidence": 0.9
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 24,
      "from": 19,
      "beatId": "fe8c99d1-59ae-4350-9a12-ffd07cd22e0a",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Traction",
      "beatSlug": null,
      "evidence": "Preliminary efficacy and safety data are presented.",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [
    {
      "to": 24,
      "from": 19,
      "name": "Day In Life",
      "slug": "14-day-in-life",
      "bestFor": "Product demos, UX reviews, investor pitches focusing on pain points",
      "matchId": "a5849bfd-1f57-46db-8128-2b35af72eb66",
      "evidence": "Preliminary efficacy data are presented.",
      "position": 1,
      "objective": "How do patients benefit from Nuvalent's therapies?",
      "structure": "The User's Struggle -> The Intervention (Your Solution) -> The Resolved State",
      "confidence": 0.6,
      "description": "Humanize abstract data by walking through a single user's struggle and resolution"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}